Last reviewed · How we verify
Klebsiella Pyelonephritis
Approved treatments
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Cefepim · University Hospital Tuebingen
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Klebsiella Pyelonephritis patent landscape — cliff calendar, originator estates, attackable patents
- Klebsiella Pyelonephritis treatment landscape brief
- Klebsiella Pyelonephritis treatment updates RSS
Frequently asked questions about Klebsiella Pyelonephritis
What drugs treat Klebsiella Pyelonephritis?
Tracked treatments include Maxipime, Cefepim, Invanz.
What is the treatment for Klebsiella Pyelonephritis?
Standard treatment for Klebsiella Pyelonephritis includes Maxipime, Cefepim, Invanz. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Klebsiella Pyelonephritis patent cliff · Klebsiella Pyelonephritis CI report
- Treatment: Maxipime · Baxter
- Treatment: Maxipime · Baxter
- Treatment: Cefepim · University Hospital Tuebingen
- Treatment: Invanz · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing